Society

About

The European Society of Cardiovascular Radiology (ESCR) is a non-profit medical society based in Vienna, Europe, dedicated to promoting and advancing cardiovascular imaging by offering Annual Scientific Meetings, workshops, webinars, as well as other scientific and educational events.

Dear members of ESCR,
Dear colleagues and friends,

I am extremely honored to have been elected as the next president of ESCR. This is a huge privilege, but also a very big responsibility, which I can only hope to fulfill.

As you certainly can imagine, with most new challenges, one is only partially aware of what to expect and of the challenges to be faced. I have a tremendous respect of the task standing in front of me and I will give my best to continue in the direction of serving our beloved society to help achieve its goals and to promote cardiovascular imaging in the radiological community. I am extremely grateful for the trust in me and I am also extremely confident that the Executive Committee will work together harmoniously and effectively.

As a guideline to my tenure as a president, I would like to stress the importance of being open and inclusive. This for me also means embracing the challenges brought by social, technological, economic, and political changes. And it means working towards unity while respecting and protecting diversity.

Thank you all!

Dr. Luigi Natale

ESCR Society President

Statutes

The ESCR Society Statutes are available for download/viewing as PDF documents:

COMMITTEES (2020-2022)

EXECUTIVE BOARD

President L. Natale, Rome/IT
Vice President R. Vliegenthart, Groningen/NL
Past President J. Bremerich, Basel/CH
Secretary R. Salgado, Antwerp/BE
Treasurer K. Nikolaou, Tuebingen/DE
Chairperson Scientific Committee M. Francone, Rome/IT
Chairperson Education & EBCR Committee K-F. Kreitner, Mainz/DE
Chairperson Membership Committee B. Velthuis, Utrecht/NL
Chairperson Communication & New Media Committee R. Budde, Rotterdam/NL
Chairperson Guidelines Committee C. Loewe, Vienna/AT
Member J-N. Dacher, Rouen/FR
Member C. Peebles, Southampton/UK
SCIENTIFIC & MRCT REGISTRY COMMITTEE

Chairperson
Marco Francone, Rome/Italy
Members
Hildo Lamb, Leiden/Netherlands
Giuseppe Muscogiuri, Rome/Italy
Felix Meinel, Rostock/Germany
Francesco Secchi, Milan/Italy
Julian A. Luetkens, Bonn/Germany
Jordi Broncano, Cordoba/Spain
Matthias Gutberlet, Leipzig/Germany

MEMBERSHIP COMMITTEE

Chairperson
Birgitta Velthuis, Utrecht/Netherlands
Members
Giles Roditi, Glasgow/United Kingdom
Katarzyna Gruszczynska, Katowice/Poland
Riccardo Marano, Rome/Italy
Matthias Eberhard, Zurich/Switzerland
Marian Pop, Targu-Mures/Romania
Niki Lama, Athens/Greece

GUIDELINES COMMITTEE

Chairperson
Christian Loewe, Vienna/Austria
Members
Luca Saba, Cagliari/Italy
Marc Dewey, Berlin/Germany
Nicola Galea, Rome/Italy
Federico Caobelli, Basel/Switzerland
Thomas Weikert, Basel/Switzerland
Michelle Williams, Edinburgh/United Kingdom
Alban Redheuil, Paris/France
Nadine Kawel-Böhm, Chur/Switzerland

EDUCATION & EBCR COMMITTEE

Chairperson
Karl-Friedrich Kreitner, Mainz/Germany
Members
Alexandros Kallifatidis, Thessaloniki/Greece
Maja Hrabak-Paar, Zagreb/Croatia
Maja Pirnat, Maribor/Slovenia
Fabio Greco, Pordenone/Italy
Dominika Sucha, Utrecht/Netherlands
Agnes Mayr, Innsbruck/Austria

COMMUNICATION & NEW MEDIA COMMITTEE

Chairperson
Ricardo Budde, Rotterdam/Netherlands
Members
Monika Radikė (birthname Aržanauskaitė), Liverpool/United Kingdom
Tommaso D’Angelo, Messina/Italy
Firdaus Mohamed Hoesein, Utrecht/Netherlands
Sara Boccalini, Bron/France
Marguerite Faure, Wilrijk/Belgium

ESCR REPRESENTATIVES AND OTHER COMMITTEES

ESR Subspecialty and Allied Sciences Committee
J. Bremerich, Basel/CH

ESR Education Committee
K-F. Kreitner (Mainz/DE)

ESR Research Committee
M. Francone, Rome/IT

ESR Quality, Safety and Standards Committee
Ch. Peebles, Southampton/UK

Advisory Editorial Board
M. Gutberlet, Leipzig/DE

ESR/EANM Joint Position Statement on Multimodality Imaging in Cardiology
M. Gutberlet, Leipzig/DE
M. Rees, Gwynedd/UK

SOCIETY CONTROLLERS

Term of Office: 2022
Mr. Christoph Mayer, Vienna/AT
Mr. Georg Varga, Vienna/AT

Partners

The European Society of Cardiovascular Radiology is happy to announce a closer collaboration with the following companies/societies:

ESCR would like to thank Bracco for their Corporate Membership and valuable support.

Interested in partnership?

Please contact ESCR Office for more information.

Young Club

ABOUT THE YOUNG CLUB

The ESCR Young Club is a working group of medical or PhD students, residents and young radiologists until the age of 35 (incl. the age of 35) with an interest in cardiovascular radiology.
The aim is to create connections and foster collaborations between young specialists and researchers, by providing an international communication platform to share experiences, exchange ideas and knowledge, and opportunities for social interaction.

THE YOUNG CLUB BOARD 2020-2022

CHAIRPERSON - Sonja Jankovic, Nis/Serbia

I’m Sonja Jankovic, a third-year radiology resident focused on cardiovascular imaging. Currently, I work at the University Clinical Center Nis, Serbia. My special interests include clinical and research multimodality imaging, especially cardiac CT and MRI, as well as the application of AI in cardiovascular imaging.

SECRETARY - Moritz Halfmann, Mainz/Germany

Moin! I’m Moritz Halfmann, a German radiologist in training at the Department for Diagnostic and Interventional Radiology at the University Medical Center in Mainz. My research is focussed on multiparametric cardiac MRI.

BENEFITS

– Meet young radiologists, experts and make new friends
– Discuss your work and research
– Receive updates on upcoming events
– Help shaping the future of cardiovascular radiology
– Learn more about cardiovascular imaging from the ESCR Webinars
– Attend Young Club initiatives for aspiring cardiovascular radiologists during ESCR Annual Scientific Meetings

VICE-CHAIRPERSON - Marco Gatti, Turin/Italy

Ciao a tutti! I am Marco Gatti, an Italian radiologist. I am currently working as a research fellow at the Department of Radiology of the University of Turin. My research and clinical interests mainly include advanced cardiac MRI techniques.

BOARD MEMBER - Mariia Tregubova, Kyiv/Ukraine
Vitayu! My name is Mariia Tregubova and I’m a radiologist in Amosov National Institute of Cardiovascular Surgery of the Academy of Medical Sciences of Ukraine, located in Kyiv. I am engaged in both clinical and research activity. Cardiac CT in adult and paediatric patients is of particular interest to me.

YOUNG CLUB BULLETINS

We are proud to present the ESCR Young Club Bulletins.
In case of any suggestions, comments, questions, please do not hesitate to contact the ESCR Office.

Enjoy the reading!

JOIN US

ESCR member

Age

3 + 7 =

MR/CT Registry

The MR/CT Registry is a database for cardiovascular radiologists to upload their cases and examinations anonymously. At the same time they have the possibility to review cases of other registered persons.

https://www.mrct-registry.org

CT Submissions

MR Submissions

Contributing users

Participating institutes

as per June 17, 2022

The aim of the registry is to document anonymous Cardiac CT- and MR- examinations, which have been performed in Europe, as complete as possible. This seems to be necessary to get a thorough overview of the already existing relevance of these challenging new possibilities in radiology. Further education in the emerging techniques of Cardiac Imaging will be supported.
The registry additionally intends to recruit teachers and identify potential training centers throughout Europe. Furthermore, the MR/CT registry does document and certify personally performed Cardiac CT- and MR-examinations for the application of further qualifying procedures (e.g. European Diploma in Cardiovascular Diploma, etc.). This is necessary on a European as well as on a national level.

STATISTICS

To get an overview of the newest updates, statistics and numbers on the MR/CT Registry download the MR/CT Booklet.

PUBLICATIONS

Gadolinium-based Contrast Agents for Cardiac MRI

The European Society of Cardiovascular Radiology (ESCR) proudly presents an article on “Gadolinium-based Contrast Agents for Cardiac MRI: Use of Linear and Macrocyclic Agents with Associated Safety Profile from 154 779 European Patients”, which now is available for download free of charge via the link below.

5

Objectives

To assess current use and acute safety profiles of gadolinium-based contrast agents (GBCAs) in cardiac MRI given recent suspensions of GBCA approval.

5

Results

A total of 154 779 patients (average age, 53 years 6 19 [standard deviation]; 99 106 men) who underwent cardiac MRI were included, the majority of whom underwent administration of GBCAs (94.2% [n = 145 855]). While linear GBCAs were used in 15.2% of examinations through 2011, their use decreased to less than 1% in 2018 and 2019. Overall, 0.36% (n = 556) of AAEs were documented (mild, 0.12% [n = 178]; moderate, 0.21% [n = 331]; severe, 0.03% [n = 47]). For nonenhanced cardiac MRI, examination- related events were reported in 2.59% (231 of 8924) of cases, the majority of which were anxiety (0.98% [n = 87]) and dyspnea (0.93% [n = 83]). AAE rates varied significantly by pharmacologic stressor, GBCA molecular structure (macrocyclic vs linear GBCA: multivariable odds ratio, 0.634; 95% confidence interval: 0.452, 0.888; P = .008), GBCA subtype, and imaging indication.

5

Methods

Patients were retrospectively included from the multinational multicenter European Society of Cardiovascular Radiology (ESCR) MR/CT Registry collected between January 2013 and October 2019. GBCA-associated acute adverse events (AAEs) were classified as mild (self-limiting), moderate (pronounced AAE requiring medical management), and severe (life threatening). Multivariable generalized linear mixed-effect models were used to assess AAE likelihood.

5

Conclusion

Gadolinium-based contrast agent administration changed according to recent regulatory decisions, with use of macrocyclic agents almost exclusively in 2018 and 2019; these agents also demonstrated a favorable acute safety profile.

 

Acute Adverse Events in CMR of the MR/CT Registry

The European Society of Cardiovascular Radiology (ESCR) proudly presents an article on “Acute adverse events in cardiac MR imaging with gadolinium-based contrast agents: results from the European Society of Cardiovascular Radiology (ESCR) MRCT Registry in 72,839 patients”, which now is available for download free of charge via the link below.

We are really proud of that first paper on the Acute Adverse Events in CMR of the ESCR Cardiac MRCT Registry, which nicely demonstrates, that CMR and especially Stress CMR is a safe and reliable method.

Prof. Dr. med. Matthias Gutberlet

Chairperson of the MRCT Registry Steering Committee

5

Objectives

To assess the incidence of acute adverse events (AAEs) in gadolinium-enhanced cardiac magnetic resonance (CMR) imaging.

5

Results

In the study population of 72,839 GBCA-enhanced CMRs, a total of 260 AAEs were reported (0.36%), with a minority of severe AAEs (n = 24, 0.033%). Allergic-like AAEs were less likely than physiologic AAEs (29% versus 71%). Patients without pharmacological stress imaging had a lower AAE rate (0.22%) compared to stress imaging (0.75%), with the highest AAE rates for regadenoson (2.95%). AAE rates also varied by GBCA subtype (overall p < 0.001). There was significant interaction between GBCA and pharmacological stressor (interaction p = 0.025), with AAE rates ranging between 0 and 10% for certain GBCA/stressor combinations. There was further marginal evidence that higher GBCA volume was associated with higher AAE incidence (OR = 1.02, p = 0.05).

5

Methods

Gadolinium-based contrast agent (GBCA)–enhanced CMR data from the multinational, multicenter European Society of Cardiovascular Radiology MRCT Registry was included. AAE severity was classified according to the American College of Radiology Manual on Contrast Media (mild, moderate, severe). Multivariable generalized linear mixed effect models were used to assess the likelihood of AAEs in various GBCA, adjusting for pharmacological stressor, main indications (i.e., suspected or known coronary artery disease or myocarditis), age, sex, and submitting center as a random effect.

5

Conclusion

GBCA-enhanced CMR imaging demonstrates low AAE rates comparable to those of other body regions. AAE likelihood correlates with GBCA subtype, pharmacological stressor, and imaging indication. Intravenous fluid administration in patients with cardiac impairment might contribute to these findings.

 

Endorsement

The ESCR board may endorse and support national workshops and congresses if such events fulfill the following rules:
1)      ESCR board members will be included in the programme planning committee
2)      ESCR board members will be actively involved in the time scheduled and organisation of the event
3)      ESCR logo will be included in a local event advertisement after agreement of ESCR board members
4)      ESCR will promote the events by his members network, website and during webinars

In counterpart ESCR board members will be invited to such events; all the costs for traveling and local accommodation will be charged to the local organisation committee. ESCR board members will travel in economy class and local expense will not exceed what could be considered as reasonable by both parties. The number of invited ESCR board members will be set in agreement between both parties.

ESCR shall not be charged by the local organisation committee. ESCR will not be responsible for the financial aspect of the events.
The local organisation committee and local attendees of the event should fulfill the rules of the reduced ESCR membership fee as it works through main countries in Europe.

The Scientific Committee Chairperson and Education Chairperson shall decide whether the event will be endorsed. In order to apply for endorsement please send your documents 6 months prior to your event to office@escr.org.